The top five tweets: From biosimilars to pharma apps — what are EPM readers interested in this week?

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics.

5. Making into our list for the week at five is the approval recommendation of biosimilar trastuzumab.

4. The item on new package of support to accelerate access to medicines and tech comes in at number four this week.

3. Third place goes to the report on the declining success of pharma apps from Research2Guidance.

2. A topic that is no stranger to our top five and running up this week is another Brexit story, this time from Med-Tech Innovation News, discussing how healthcare is weathering the Brexit storm.

1. Taking the top spot this week is the news about Zenith Technologies’ workforce growth to meet the increased demand for its solutions.